Latest Breaking News On - Werewolf therapeutics - Page 1 : comparemela.com

Investment Analysts' Recent Ratings Changes for Werewolf Therapeutics (HOWL)

A number of research firms have changed their ratings and price targets for Werewolf Therapeutics (NASDAQ: HOWL): 6/4/2024 – Werewolf Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock. 6/3/2024 – Werewolf Therapeutics had its “outperform” rating reaffirmed by analysts at Wedbush. […]

Health sciencesLighthouse investment partnersVanguard group incNews ratings for werewolf therapeutics inc dailyWerewolf therapeutics incFinancial perspectives incWerewolf therapeuticsTherapeutics stock downGet free reportInvestment partnersPerspectives incVanguard groupWerewolf therapeutics inc daily

Short Interest in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Decreases By 10.3%

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 372,000 shares, a drop of 10.3% from the April 30th total of 414,500 shares. Based on an average daily volume of 185,300 shares, […]

Werewolf therapeutics incFinancial perspectives incDenali advisorsWerewolf therapeutics company profileAcadian asset managementLighthouse investment partnersWerewolf therapeuticsGet free reportTherapeutics stock downPerspectives incInvestment partnersAsset managementWerewolf therapeutics daily

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesEllen lubmanRandi isaacsJosh rappaportDanielj hicklinGlobenewswire incScientific communicationsWerewolf therapeutics incCompany contactCompany or werewolf nasdaqChief executive officerChief medical officerGlobal healthcare conferenceYork cityWerewolf therapeutics

HC Wainwright Reiterates "Buy" Rating for Werewolf Therapeutics (NASDAQ:HOWL)

HC Wainwright restated their buy rating on shares of Werewolf Therapeutics (NASDAQ:HOWL – Free Report) in a research report released on Friday morning, Benzinga reports. The firm currently has a $15.00 price objective on the stock. Other equities analysts have also recently issued research reports about the stock. Wedbush reiterated an outperform rating and issued […]

Lighthouse investment partnersFinancial perspectives incWerewolf therapeutics incAcadian asset managementDenali advisorsWerewolf therapeutics company profileWerewolf therapeuticsFree reportGet free reportPerspectives incInvestment partnersAsset managementWerewolf therapeutics daily

Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know - Werewolf Therapeutics (NASDAQ:HOWL)

Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know - Werewolf Therapeutics (NASDAQ:HOWL)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Werewolf therapeutics incHealth careWerewolf therapeuticsAnalyst ratingsTherapeutics incCapitalization analysisRevenue trendExamining werewolf therapeutics